Investor Deck

March, 2021

StellaDX Investor Deck - March 2021.pdf

GenomeWeb: Stella Diagnostics, Mayo Clinic Collaborating on Barrett's Esophagus Protein Markers

StellaDX Company Update

ICR 32nd Annual Conference

Available On-Demand to Registered ICR Participants for 90 days

Track 1 - 1pm Session - January 14th

Data Presentation

"Discovery Proteomics Detects Expression Trends Associated with Resistance to the Most Commonly Used Chemotherapies in Esophageal Adenocarcinoma" Mittal, et al.

AACR-NCI Chemoresistance Poster_Mittal et al_high res.pdf

Stella Diagnostics CEO, Joe Abdo, Featured as Rising Entrepreneur by Georgetown University Medical Center


Georgetown University Graduate Students Share Their Experience Working at Stella Diagnostics


Investors and Media Contact:

Tel: 201-381-1474